Merck and Co

Merck inks $2 B agreement with Hengrui Pharma for cardiovascular drug BioSpectrum Asia08:27Merck China Pharma

Merck inks $2B licensing deal with Chinese biotech for oral heart drug Zacks12:34Merck China Pharma

What’s the (re)issue? Patent term extensions for reissue patents National Law Review19:31Intellectual Property Pharma US

Federal Circuit clarifies patent term extension calculation for reissue patents JD Supra17:18Intellectual Property Pharma US

Positive phase III data gives Merck potential boost for blockbuster Keytruda in injection form Yahoo! US15:02Pharma

Merck releases positive data for blockbuster cancer drug Yahoo! US20:28Pharma

GameStop, fst corp, Merck, ups, and Tesla: Why these 5 stocks are on investors' radars today Benzinga01:55Stock Markets (World) Tesla, Inc. Stock Market

Palette of evidence: Ptab must consider entire record to determine prior art status JD Supra20:59Patent Law Intellectual Property Pharma

Federal Circuit touches on appellate standing and prior Art determinations in the context of post-grant review… JD Supra19:44Patent Law Intellectual Property Pharma

Merck gets EC nod for 21-valent pneumococcal jab CAPVAXIVE Zacks15:00Pneumonia European Commission Pharma

Merck and Hengrui strike $2B deal for Lipoprotein(a) drug ENDPOINTS10:36Pharma

Merck’s Tepmetko, BeOne Medicines’ Tevimbra to be covered by insurance starting April Korea Biomedical Review01:32Pharma

Federal Circuit decision could encourage more reissue patents National Law Review17:55Intellectual Property FDA US

Federal Circuit: Reissue patents get PTE based on the original patent’s issue date JD Supra15:05Intellectual Property FDA US

Big Pharma on edge as US-EU tariff spat poses risk for drug sales Daily Sabah11:04Ozempic Cancer Treatment Pharma

Big pharma fears best-selling Irish drugs in crosshairs of Trump tariffs BreakingNews.ie13:51Ozempic Cancer Treatment Pharma

Latest News

In the last 4 hours

Merck releases positive data for blockbuster cancer drug Yahoo! US20:28

Zebra Technologies and Merck KGaA, Darmstadt, Germany Collaborate to Create Safety and… Business Wire (Press Release)19:54

What’s the (Re)issue? Patent Term Extensions for Reissue Patents National Law Review19:31

In the last 6 hours

Merck details injectable Keytruda data as it awaits FDA decision ENDPOINTS18:33

Investors who lost money on Merck & Co., Inc. (MRK) should contact Levi & Korsinsky about pending Class Action - MRK GlobeNewswire (Press Release)16:54

Rosen, leading trial attorneys, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in… GlobeNewswire (Press Release)16:54

In the last 8 hours

Merck lays out subcutaneous Keytruda data in lung cancer amid patent brawl with Halozyme FiercePharma15:10

Merck’s Investigational Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Demonstrates… Business Wire (Press Release)15:09

Positive phase III data gives Merck potential boost for blockbuster Keytruda in injection form Yahoo! US15:02

Merck Gets EC Nod for 21-Valent Pneumococcal Jab Capvaxive Zacks15:00

Earlier today

Is Merck Stock a Bargain Buy? The Motley Fool12:40

Merck and Zebra Technologies Collaborate to Create Safety and Traceability ... Merck Group (Press Release)09:06

Merck inks $2 B agreement with Hengrui Pharma for cardiovascular drug BioSpectrum Asia08:27

Yesterday

Faruqi & Faruqi Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, … GlobeNewswire (Press Release)19:34 26-Mar-25

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Merck & Co., Inc. (MRK) Shareholders GlobeNewswire (Press Release)15:16 26-Mar-25

Merck Inks $2B Licensing Deal With Chinese Biotech for Oral Heart Drug Zacks12:34 26-Mar-25

Merck gains rights to Hengrui’s heart disease candidate in deal worth almost $2bn PMLiVE12:33 26-Mar-25

European Commission (EC) Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) … Business Wire (Press Release)10:49 26-Mar-25

Gamestop, Fst Corp, Merck, ups, And Tesla: Why These 5 Stocks Are On Investors' Radars Today Benzinga01:55 26-Mar-25

In the last 7 days

Merck, Hengrui Launch Up-to-$2B+ Cardiometabolic Collaboration Genetic Engineering and Biotechnology News23:21 25-Mar-25

Merck Doubles Down On Oral Lipid-Lowering Drugs With Hengrui’s Lp(a) Asset Scrip Pharma Intelligence23:08 25-Mar-25

For nearly $2B, Jiangsu Hengrui licenses heart drug to Merck BioWorld21:03 25-Mar-25

Merck Betting Up To $2B On China-Developed Cardio Drug Law36019:30 25-Mar-25

Merck forks out US$2b for Chinese heart drug Hong Kong Standard19:12 25-Mar-25

Federal Circuit Clarifies Patent Term Extension Calculation for Reissue Patents JD Supra17:18 25-Mar-25

Merck Partners With Hengrui Pharma In $1.77 Billion Deal For Cardiovascular Treatment Benzinga17:00 25-Mar-25

Merck bets $200M on a new type of heart pill BioPharma Dive16:19 25-Mar-25

Merck (NYSE:MRK) Becomes Latest Big Pharma Stock to Tap China with $2B Heart Disease Drug… TipRanks15:19 25-Mar-25

MRK Investors Have Final Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with… PR Newswire (Press Release)13:44 25-Mar-25

Cell Therapy Technologies Market Report, Growth Forecasts for 2025-2030 and Profiles of Danaher, Merck, Lonza,… GlobeNewswire (Press Release)13:40 25-Mar-25

Merck signs deal with Jiangsu Hengrui worth up to $2 billion for access to heart drug KELO TV12:49 25-Mar-25

Merck signs deal with Jiangsu Hengrui for access to heart drug The Financial Express12:21 25-Mar-25

First Patient Dosed in Immutep’s Tacti-004 Phase III Trial in First Line Non-Small Cell Lung Cancer GlobeNewswire (Press Release)12:09 25-Mar-25

Merck Enters Exclusive License Agreement for HRS-5346, an Investigational Oral Lipoprotein(a)… Business Wire (Press Release)10:51 25-Mar-25

Mural Oncology Provides Update on Phase 3 artistry-7 Trial of Nemvaleukin in Combination with Keytruda® (pembrolizumab) … GlobeNewswire (Press Release)10:36 25-Mar-25

Merck and Hengrui strike $2B deal for Lipoprotein(a) drug ENDPOINTS10:36 25-Mar-25

Merck Animal Health Donates $50,000 To The Nat'l Professional Ag Student Organization AgriMarketing07:00 25-Mar-25

Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc. (Fed. Cir. 2025) JD Supra18:22 24-Mar-25

Federal Circuit Decision Could Encourage More Reissue Patents National Law Review17:55 24-Mar-25

Merck & Co., Inc. (NYSE: MRK) deadline alert: Bernstein Liebhard LLP Reminds Merck & Co., Inc. Investors of Upcoming… GlobeNewswire (Press Release)16:18 24-Mar-25

Global Cancer Antibody Drug Conjugates Market Landscape 2024-2030 Featuring Biocytogen, Merck, AstraZeneca, Pfizer,… GlobeNewswire (Press Release)09:11 24-Mar-25

Shareholder action reminder: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. GlobeNewswire (Press Release)12:50 23-Mar-25

Merck Vs. Bristol-Myers Squibb: Which Pharma Stock Should You Buy Seeking Alpha02:30 23-Mar-25

2 Beaten-Down Stocks to Buy on the Dip The Motley Fool20:06 22-Mar-25

World Cancer Day 2025: Merck Foundation enhances Access to Cancer Care by providing 194… African Press Organization12:17 22-Mar-25

J&J Joins Pharma Peers With $55bn In Manufacturing And Other US Spending Scrip Pharma Intelligence22:00 21-Mar-25

Palette of Evidence: PTAB Must Consider Entire Record to Determine Prior Art Status JD Supra20:59 21-Mar-25

Levi & Korsinsky Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming… PR Newswire (Press Release)09:45 21-Mar-25

Merck (NYSE:MRK) Unveils New Data On Cardiovascular Advances At ACC.25 Annual Conference Simply Wall St02:02 21-Mar-25

Merck’s Tepmetko, BeOne Medicines’ Tevimbra to be covered by insurance starting April Korea Biomedical Review01:32 21-Mar-25

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FMC, TransMedics,… GlobeNewswire (Press Release)01:00 21-Mar-25

The Gross Law Firm Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April… GlobeNewswire (Press Release)17:02 20-Mar-25

Merck to lay off 163 workers in Pennsylvania; Delpharm gets $60M from Canadian government ENDPOINTS16:05 20-Mar-25

Federal Circuit: Reissue Patents Get PTE Based on the Original Patent’s Issue Date JD Supra15:05 20-Mar-25

In the last month

Merck, Schering Notch Partial Win in Zetia Drug Monopoly Claims Bloomberg Law21:47 19-Mar-25

Federal Circuit: PTE for Reissue Patents Should Be Calculated From Original Patent’s Issue Date JD Supra19:54 19-Mar-25

Federal Circuit Touches on Appellate Standing and Prior Art Determinations in the Context of Post-Grant Review… JD Supra19:44 19-Mar-25

Anti-Venom Market Forecast Report and Company Analysis 2025-2033 Featuring Bharat Serums and Vaccines, Boehringer… GlobeNewswire (Press Release)16:18 19-Mar-25

Urinary Tract Infection Treatment Market Forecast Report and Company Analysis 2025-2033 Featuring AstraZeneca, Bayer,… GlobeNewswire (Press Release)16:18 19-Mar-25

Merck KGaA’s SMARTfacturing Ecosystem Vision Genetic Engineering and Biotechnology News16:13 19-Mar-25

Ongoing deadline alert: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. GlobeNewswire (Press Release)15:27 19-Mar-25

Merck Loses Almost $52B in 6 Months: How to Play MRK Stock Zacks13:40 19-Mar-25

Merck Foundation: ‘More Than A Mother,’ ‘Diabetes & Hypertension’ Songs Award Winners Emerge Independent Nigeria04:02 19-Mar-25

Patent Case Summaries | Week Ending March 14, 2025 JD Supra00:54 19-Mar-25

Pa. plant to close in 2026; 163 people to be laid off PennLive.com, Pennsylvania21:29 18-Mar-25

Big pharma fears best-selling Irish drugs in crosshairs of Trump tariffs BreakingNews.ie13:51 18-Mar-25

Big Pharma on edge as US-EU tariff spat poses risk for drug sales Daily Sabah11:04 18-Mar-25

Big pharma fears best-selling drugs in crosshairs of US-EU tariff spat Yahoo! US06:13 18-Mar-25

Merck plots 163 layoffs as it prepares to shutter Pennsylvania manufacturing site FiercePharma16:13 17-Mar-25

AstraZeneca signs Alteogen deal worth up to $1.35B for subcutaneous cancer drugs despite… FiercePharma15:01 17-Mar-25

Merck Foundation Chief Executive Officer (CEO) Honors Excellence in Research: Winners of Merck… African Press Organization13:03 17-Mar-25

Investor deadline approaching: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. GlobeNewswire (Press Release)12:42 15-Mar-25

American Pharmaceutical Companies Still Aren’t Paying Tax in the U.S. Council on Foreign Relations17:20 14-Mar-25

Liver Disease Therapeutic Market Forecast Report and Company Analysis 2025-2033 Featuring Abbott, Astellas, BMS, Gilead … GlobeNewswire (Press Release)11:19 14-Mar-25

Merck diversity leader to retire this summer; Geron seeks commercial chops for next CEO ENDPOINTS11:08 14-Mar-25

Merck Foundation Chief Executive Officer (CEO) and First Ladies of Africa jointly announce… African Press Organization05:39 14-Mar-25

Fed. Circ. Sides With Merck In Reissued Patent Debate Law36000:31 14-Mar-25

Merck Asks Justices To Block Fosamax Failure-To-Warn Suits Law36000:31 14-Mar-25

Merck’s HIV Combo Shows Non-Inferiority To Gilead’s Biktarvy Scrip Pharma Intelligence21:27 13-Mar-25

Merck & Co., Inc. Class Action: The Gross Law Firm Reminds Merck Investors of the Pending Class … PR Newswire (Press Release)09:55 13-Mar-25

Merck opens $1bn US vaccine manufacturing centre in Durham, North Carolina Manufacturing Chemist09:22 13-Mar-25

Kelun Wins World’s First TROP2 ADC Approval In Lung Cancer Scrip Pharma Intelligence07:11 13-Mar-25

Kelun Wins World’s First TROP2 ADC Approval In Lung Cancer, Merck Left Out Scrip Pharma Intelligence05:29 13-Mar-25

Celonic Integrates Merck’s Breez Micro-Bioreactor Platform Into Its Process Development Operations Genetic Engineering and Biotechnology News20:43 12-Mar-25

Msd bolsters US manufacturing capacity with $1b investment European Pharmaceutical Review17:47 12-Mar-25

#CROI25: Merck’s troubled HIV drug heads to regulators; ViiV seeks longer-acting HIV drug ENDPOINTS15:32 12-Mar-25

Merck Announces Positive Data from Phase 3 Trials that Show the Investigational, Once-Daily,… Business Wire (Press Release)15:27 12-Mar-25

Merck defeats claims it should have added safety warnings to Gardasil's label, knocking out… FiercePharma15:20 12-Mar-25

Merck KGaA’s Mavenclad tablets recommended by NICE for wider MS use PMLiVE12:23 12-Mar-25

Celonic Group Leverages Merck’s Breez™ Micro-Bioreactor Platform, Enabling Next-Generation Perfusion-Based Bioprocessing Biotech, B3C newswire12:07 12-Mar-25

Merck MS tablet set for wider use by NHS in England pharmaphorum11:08 12-Mar-25

Judge: 'Evidence Is Lacking' to Impose Warning on HPV Vaccine Gardasil Law.com21:25 11-Mar-25

Merck prevails in Gardasil safety litigation KELO TV21:14 11-Mar-25

Federal Judge Rules in Merck’s Favor in Gardasil Safety Suit Bloomberg Law20:14 11-Mar-25

Merck opens new $1B vaccine manufacturing plant in North Durham News & Observer, North Carolina19:30 11-Mar-25

Dow Analyst Moves: MRK Nasdaq19:21 11-Mar-25

Merck opens $1B Gardasil manufacturing facility in North Carolina FiercePharma18:19 11-Mar-25

Merck dodges ‘failure to warn’ claims in federal Gardasil cases ENDPOINTS17:41 11-Mar-25

Federal Circuit Says Indemnity Agreement with Customer Satisfies Article III Standing IPWatchdog.com17:33 11-Mar-25

Stock Watch: Hesitant Vaccine Sales For CSL Reflect Wider Issues Scrip Pharma Intelligence15:10 11-Mar-25

Investor alert: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. GlobeNewswire (Press Release)14:12 11-Mar-25

Zacks Investment Ideas feature highlights: Molson Coors, Merck & Co. and Deutsche Telekom Zacks14:09 11-Mar-25

Merck opens billion-dollar facility to make bladder cancer immunotherapy ENDPOINTS13:57 11-Mar-25

Merck opens vaccine manufacturing facility in North Carolina KELO TV12:44 11-Mar-25

Merck opens $1 billion addition in north Durham to boost production of popular vaccine News & Observer, North Carolina10:51 11-Mar-25

Merck Unveils New Facility to Increase Vaccine Production Capacity Business Wire (Press Release)10:48 11-Mar-25

Rosen, leading investor counsel, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in… GlobeNewswire (Press Release)22:26 10-Mar-25

Merck Foundation Chief Executive Officer (CEO) together with African First Ladies Africa mark… African Press Organization12:07 9-Mar-25

Merck virologist recalls becoming whistleblower over maker's blockbuster MMR measles, mumps vaccine Just The News04:06 8-Mar-25

Merck’s lupus drug fails in SLE cohort of Phase II trial Clinical Trials Arena12:02 7-Mar-25

Merck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact Levi &… PR Newswire (Press Release)10:53 7-Mar-25

Merck KGaA reports YE24 earnings growth amid SpringWorks acquisition talks Pharmaceutical Technology22:26 6-Mar-25

The Gross Law Firm Reminds Merck & Co., Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff… GlobeNewswire (Press Release)17:19 6-Mar-25

In patent clash over injectable Keytruda, Merck and Halozyme dig in for a fight FiercePharma16:36 6-Mar-25

Merck KGaA Talks More Deals But Stays Silent On SpringWorks Scrip Pharma Intelligence16:23 6-Mar-25

view more headlines

27 Mar 20:28

Merck & Co News

NewsNow aims to be the world's most accurate and comprehensive aggregator of Merck & Co news, covering the latest MSD share price, Merck Sharp & Dohme company announcements, product trials, pharmaceutical news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.